Adenoid cystic carcinoma: A review of recent advances, molecular targets, and clinical trials

MYBGene Abnormalities t(6;9) in Adenoid Cystic Carcinoma Fine-Needle Aspiration Biopsy Using Fluorescence In Situ Hybridization

(2014) Jena B. Hudson et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Expression of beclin 1 in primary salivary adenoid cystic carcinoma and its relation to Bcl-2 and p53 and prognosis

(2014) L.C. Jiang et al.   BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH

A rationale for chemoradiation (vs radiotherapy) in salivary gland cancers? On behalf of the REFCOR (French rare head and neck cancer network)

(2014) Thomas Cerda et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Adenoid Cystic Carcinoma of the Breast: A Case Series of Six Patients and Literature Review

(2014) Miso Kim et al.   Cancer Research and Treatment

Expression and significance of notch signaling pathway in salivary adenoid cystic carcinoma

(2013) Diana Bell et al.   Annals of Diagnostic Pathology

Cetuximab and platinum-based chemoradio- or chemotherapy of patients with epidermal growth factor receptor expressing adenoid cystic carcinoma: a phase II trial

(2013) E Hitre et al.   BRITISH JOURNAL OF CANCER

MYB immunostaining is a useful ancillary test for distinguishing adenoid cystic carcinoma from pleomorphic adenoma in fine-needle aspiration biopsy specimens

(2013) Marc P. Pusztaszeri et al.   CANCER CYTOPATHOLOGY

Comprehensive genomic profiling of epithelial ovarian cancer by next generation sequencing-based diagnostic assay reveals new routes to targeted therapies

(2013) J.S. Ross et al.   GYNECOLOGIC ONCOLOGY

Mutation signature of adenoid cystic carcinoma: evidence for transcriptional and epigenetic reprogramming

(2013) Henry F. Frierson et al.   JOURNAL OF CLINICAL INVESTIGATION

The mutational landscape of adenoid cystic carcinoma

(2013) Allen S Ho et al.   NATURE GENETICS

Malignant salivary gland tumours: Can fast neutron therapy results point the way to carbon ion therapy?

(2013) Clare Stannard et al.   RADIOTHERAPY AND ONCOLOGY

Adenoid cystic carcinoma of the head and neck

(2012) Christopher J. Balamucki et al.   AMERICAN JOURNAL OF OTOLARYNGOLOGY

Disposition and metabolism of 14C-dovitinib (TKI258), an inhibitor of FGFR and VEGFR, after oral administration in patients with advanced solid tumors

(2012) Anne-Charlotte Dubbelman et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Clinically significant copy number alterations and complex rearrangements ofMYBandNFIBin head and neck adenoid cystic carcinoma

(2012) Marta Persson et al.   GENES CHROMOSOMES & CANCER

A phase II study of sunitinib in recurrent and/or metastatic adenoid cystic carcinoma (ACC) of the salivary glands: current progress and challenges in evaluating molecularly targeted agents in ACC

(2011) N. G. Chau et al.   ANNALS OF ONCOLOGY

A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck

(2011) Athanassios Argiris et al.   CANCER

A comparison of the demographics, clinical features, and survival of patients with adenoid cystic carcinoma of major and minor salivary glands versus less common sites within the Surveillance, Epidemiology, and End Results registry

(2011) Nan Li et al.   CANCER

Development and characterization of xenograft model systems for adenoid cystic carcinoma

(2011) Christopher A Moskaluk et al.   LABORATORY INVESTIGATION

Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms

(2011) Louis B Brill et al.   MODERN PATHOLOGY

Phase II study of cisplatin and imatinib in advanced salivary adenoid cystic carcinoma

(2010) Niladri Ghosal et al.   BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY

New tricks from an old oncogene

(2010) Goran Stenman et al.   CELL CYCLE

Comprehensive Analysis of the MYB-NFIB Gene Fusion in Salivary Adenoid Cystic Carcinoma: Incidence, Variability, and Clinicopathologic Significance

(2010) Y. Mitani et al.   CLINICAL CANCER RESEARCH

Chemotherapy and targeted therapy in adenoid cystic carcinoma of the head and neck: A review

(2010) Giorgos Papaspyrou et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review

(2010) Scott A Laurie et al.   LANCET ONCOLOGY

Nerve Growth Factor and Vascular Endothelial Growth Factor: Retrospective Analysis of 63 Patients with Salivary Adenoid Cystic Carcinoma

(2010) Hao Li et al.   International Journal of Oral Science

Identification of c-kit gene mutations in primary adenoid cystic carcinoma of the salivary gland

(2009) Lizette Vila et al.   MODERN PATHOLOGY

Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs)

(2009) Laura D. Locati et al.   ORAL ONCOLOGY

Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck

(2009) M. Persson et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Imatinib in the treatment of solid tumours

(2009) Florence Duffaud et al.   Targeted Oncology

Deletion of 1p32-p36 Is the Most Frequent Genetic Change and Poor Prognostic Marker in Adenoid Cystic Carcinoma of the Salivary Glands

(2008) P. H. Rao et al.   CLINICAL CANCER RESEARCH

Survival from salivary glands adenoid cystic carcinoma in European populations

(2008) Laura Ciccolallo et al.   ORAL ONCOLOGY

Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study

(2008) L.D. Locati et al.   ORAL ONCOLOGY

Outcomes and Prognostic Variables in Adenoid Cystic Carcinoma of the Head and Neck: A Recent Experience

(2007) Daniel R. Gomez et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS